Responses
Oncolytic and local immunotherapy
Original research
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.